Niacin receptor agonists, compositions containing such compounds and methods of treatment

Details for Australian Patent Application No. 2006292559 (hide)

Owner Merck & Co., Inc.

Inventors Imbriglio, Jason E.; Beresis, Richard Thomas; Colletti, Steven L.; Frie, Jessica Leslie

Agent Spruson & Ferguson

Pub. Number AU-A-2006292559

PCT Pub. Number WO2007/035478

Priority 60/718,622 20.09.05 US

Filing date 15 September 2006

Wipo publication date 29 March 2007

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/035478 Priority application(s): WO2007/035478

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292575-Improved poly aryl ether ketone polymer blends

2006292540-Agglomerated ion exchange particle bed and method